Moricizine Hydrochloride (EN 313) is an orally active Class I antiarrhythmic agent. Moricizine Hydrochloride decreases the maximum rate of phase 0 depolarization, increases rates of phase 2 and 3 repolarization, decreases action potential duration, and decreases effective refractory period[1].
Molecular Weight:
463.98
Purity:
98
CAS Number:
[29560-58-5]
Formula:
C22H26ClN3O4S
Target:
Cytochrome P450
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted